Jacob Gottlieb is the founder of Visium Asset management an investment company with global offices in New York, London, and San Francisco. Recently, Gottlieb launched his new firm, Altium, a health care oriented investment firm which is focused on investment opportunities relating to the growth of companies in the healthcare sector. Altium invested its capital in some health industries which include, Oragenics, Oramed Pharmaceuticals (ORMP), and Amarin Corporation (AMRN).
Gottlieb is an alumnus of Brown University and New York University School of Medicine graduating with BA in Economics and MD respectively. In 2010, Gottlieb was appointed as P.R.M by Professional Risk Manager`s International Association, and in the preceding year, he was awarded with Financial Analyst Charter from Investment Management and Research Association.
Gottlieb has always had the vision to bring development in the health sector through building healthcare investments. Before forming his own investments companies, he partnered with other members to form Balyasny Asset Management where he appeared as the top earner, and he gained world popularity for huge portfolio gains. He also worked at Merlin BioMed in New York City as investment portfolio manager gaining plenty of experience. For two years he worked at Sanford C. Bernstein as a buy-side analyst his main focus directed on global health care investment.
Gottlieb has partnered with two leading healthcare firm, Iguana Healthcare Partners and Bay City Capital in sharing Altium`s office space in New York. This move appeared beneficial as Gottlieb previously at Merlin BioMed worked with Stuart Weisbrod, Iguana`s founder, and CIO. The three firms working joining hands to work together opens the floodgates for new opportunities in healthcare investment sector.
Besides a successful career, Gottlieb has shown remarkable efforts in philanthropic events. He has been donating his time and resources to organizations which assists vulnerable and underserved members in the community.